Patent application number | Description | Published |
20100122784 | PROCESS FOR TREATING PULP MILL CONDENSTATES USING A HOLLOW FIBER CONTACTOR - A method and apparatus for the treatment of pulp mill condensates is described. A hollow fiber contactor, incorporating a hydrophobic membrane, was used to remove several undesirable compounds from pulp mill condensates. For example, TRS compounds and SO | 05-20-2010 |
20100263816 | USE OF CHEMICAL PULP MILL STEAM STRIPPER OFF GASES CONDENSATE AS REDUCING AGENT IN CHLORINE DIOXIDE PRODUCTION - Steam stripper off gas from chemical pulp mills, for example kraft or sulphite pulp mills is rich in methanol and totally reduced sulphur (TRS) compounds. This gaseous stream is usually burned to avoid further handling of this TRS-rich, odorous stream. We found that once this gaseous stream is condensed, it can be used as a reducing agent in the chlorine dioxide generator, in place of purchased methanol. Surprisingly, we found that, in addition to the methanol component, the TRS components act as reducing agents during the production of chlorine dioxide or, at the very least, do not consume chlorine dioxide. The use of this stream in the ClO | 10-21-2010 |
20110176989 | PROCESS FOR PRODUCING CHLORINE DIOXIDE USING WASTE GLYCEROL FROM A BIODIESEL PLANT - A process for chlorine dioxide production uses waste glycerol from biodiesel plants as a reducing agent. This untreated waste stream may contain other reducing agents such as sodium chloride and methanol which were found to enhance the chlorine dioxide production. Other chemicals present in this waste stream did not affect the operation of the chlorine dioxide generator. Substituting the waste glycerol for methanol or other reducing agents helps kraft pulp mills in reducing the cost of producing chlorine dioxide while providing a use for the untreated waste glycerol stream. | 07-21-2011 |
20120211184 | FRACTIONATION OF A WASTE LIQUOR STREAM FROM NANOCRYSTALLINE CELLULOSE PRODUCTION - During nanocrystalline cellulose (NCC) production, a considerable amount of sulphuric acid is used. After the separation of the NCC, the remaining solution contains sugars and residual sulphuric acid. The sugars are in the monomeric and oligomeric forms. To reduce the cost of NCC production and to produce other added-value products, the spent acid stream can be fractionated into sugar oligomers, sugar monomers, and acid. The acid can be recycled to the NCC manufacturing process after concentration. The sugar monomers and sugar oligomers can be used for the manufacturing of other valuable chemicals. Membrane nanofiltration can be used to achieve this objective. A polymeric membrane with a molecular weight cut-off in the range of 200 Dalton was employed. Using this approach, the majority of the acid was recovered in the permeate while the sugars were concentrated in a smaller stream. The sugar level in the separated acid/permeate stream was only about 3% of the original concentration. A second membrane filtration stage can be used to separate the monomeric from the oligomeric sugars. The two sugar streams can be employed in different applications to produce value-added products. | 08-23-2012 |
Patent application number | Description | Published |
20120220949 | MEDICATED MODULE WITH INTEGRAL FLOW DISTRIBUTION SYSTEM - A medicated module for an injection system to co-deliver at least two medicaments is disclosed where a primary delivery device containing a primary medicament accepts a medicated module containing a single dose of a secondary medicament contained within a capsule having an integral flow distributor/distribution system and where both medicaments are delivered through a single hollow needle. | 08-30-2012 |
20120226238 | MEDICATED MODULE WITH BYPASS AND NEEDLE GUARD - A medicated module attachable to a drug delivery device comprises a connecting body configured for attachment to the drug delivery device. A first needle is fixed within the connecting body and a movable needle hub is operatively coupled to the connecting body. A needle guard is operatively coupled to the connecting body and a biasing member is positioned between the connecting body and needle guard. A second needle is fixed within the needle hub. A first cavity within the connecting body defines a reservoir containing at least one dose of a medicament. The reservoir configured for fluid communication with the first and the second needle. The reservoir comprises a bypass configured to allow medicament from the drug delivery device to bypass the reservoir and exit the second needle. | 09-06-2012 |
20130041321 | MEDICATED MODULE WITH USER SELECTION - A medicated module for an injection system to co-deliver at least two medicaments is disclosed where a primary delivery device containing a primary medicament accepts a medicated module containing a single dose of a secondary medicament and where both medicaments are delivered through a hollow needle. The medicated module is user selectable so that it will deliver a priming dose of a primary medicament or both the primary and secondary medicaments. The module also contains a needle guard that locks after dose delivery. The needle guard prevents accidental needle sticks before and after an injection. A locking collar rotates during use as an inner protrusion follows three paths of a track located on the outer surface of a body housing. When the inner facing protrusion is in the third path, it encounters a hard stop and a rotational bias that locks the guard from further refraction and thus covers the sharp distal end of the needle. | 02-14-2013 |
20130046246 | NEEDLE ASSEMBLY - Disclosed is a safety needle assembly has a needle guard that prevents accidental needle sticks before and after an injection. A locking collar rotates during use as an inner protrusion follows three paths of a track located on the outer surface of a body housing. When the inner facing protrusion is in the third path, it encounters a hard stop and a rotational bias that locks the guard from further retraction and, thus, covers the sharp distal end of the needle. | 02-21-2013 |
20130204186 | MEDICATED MODULE WITH AUTOMATIC RESERVOIR ENGAGEMENT - A medicated module ( | 08-08-2013 |